Photo of James A. Himes
D United States House · District 4 · Connecticut On the 2026 ballot

Rep. James A. Himes

Compare
Total votes
2,818
all sessions
Attendance
99%
30 missed
Higher than 76% of chamber peers
With party
96%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
728
bills & resolutions
Lower than 79% of chamber peers
Committees
2
assignments
728 bills and resolutions

Sponsored bills

Total
728
Primary
22
Co-sponsor
706
This page
728
matching current filters
Co-sponsor HR 4430
Passed · Oregon House · Co-sponsor
Expanding WKSI Eligibility Act

This bill reduces the required aggregate market value of voting and non-voting common equity shares for an issuer of securities to qualify as a well-known seasoned issuer. A well-known seasoned issuer is allowed to make expedited public offerings of securities through automatic shelf registrations.

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 1262
Passed · Oregon House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 6181
In committee · Oregon House · Co-sponsor
John Lewis Every Child Deserves a Family Act

Maddy summaryHR 6181, the John Lewis Every Child Deserves a Family Act, prohibits child welfare agencies receiving federal funds from discriminating against children, youth, or prospective foster/adoptive parents based on religion, sex (including sexual orientation and gender identity), or marital status. It directly affects LGBTQ youth in foster care - overrepresented at 30% of the system - who face higher risks of trauma, group home placements, and suicide attempts compared to non-LGBTQ peers. Key provisions require agencies to collect data on sexual orientation and gender identity, establish a National Resource Center for LGBTQ youth support, provide cultural competency training, and eliminate discriminatory practices. The law aims to improve safety, permanency, and placement stability by expanding access to family-based care and ensuring equitable services for all children in the system.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6151
In committee · Oregon House · Co-sponsor
Global Respect Act

Maddy summaryThe Global Respect Act (HR 6151) requires the U.S. President to publicly list foreign officials responsible for severe human rights violations against LGBTQI individuals, including torture, prolonged detention, or violence based on sexual orientation or gender identity. It mandates denying visas and entry to listed individuals and requires annual reports on the list's updates and impacts. The bill also directs the State Department to track global violence against LGBTQI people and update annual human rights reports to include discrimination based on sexual orientation or gender identity. These provisions directly affect foreign government officials and entities implicated in such abuses, aiming to increase accountability through U.S. visa restrictions.

In committee Nov 19, 2025 1 co-sponsor
Co-sponsor HR 6161
In committee · Oregon House · Co-sponsor
SEC Data Protection Act

Maddy summaryHR 6161, the SEC Data Protection Act, requires the Securities and Exchange Commission (SEC) to establish policies protecting sensitive nonpublic data provided by investment advisers. The bill mandates that within one year of enactment, the SEC create rules addressing when it requests such data, safeguarding it based on sensitivity, restricting access to authorized staff, and preventing unauthorized use or disclosure. These policies must be developed through a notice-and-comment rulemaking process. The law directly affects investment advisers who share proprietary information with the SEC, ensuring their data is handled securely under new federal standards.

In committee Nov 19, 2025 1 co-sponsor
Co-sponsor HRES 846
In committee · Oregon House · Co-sponsor
Original National Domestic Violence Awareness Month Resolution of 2025

Maddy summaryHRES 846 is a symbolic resolution designating October 2025 as National Domestic Violence Awareness Month. It expresses the House's support for raising awareness about domestic violence and its impacts, and calls for continued congressional attention to ending domestic violence through existing programs. The resolution does not create new laws, allocate funding, or directly affect any specific groups - it is purely a statement of support. It references statistics on domestic violence prevalence but focuses on awareness rather than policy changes.

In committee Oct 31, 2025 1 co-sponsor
Co-sponsor HR 5705
In committee · Oregon House · Co-sponsor
To authorize the reimbursement by the Federal Government of State funds used to maintain participation in the Special Supplemental Nutrition Program for Women, Infants, and Children in the event of a Government shutdown.

Maddy summaryHR 5705 requires the federal government to reimburse state agencies for funds they use to maintain participation in the WIC program during a government shutdown. It directly affects states that cover WIC costs using their own money when federal funding lapses. The bill establishes a process where states can seek reimbursement from the federal government after the shutdown ends. This ensures states aren’t burdened with costs for a federal funding gap that impacts nutrition assistance for women, infants, and children.

In committee Oct 8, 2025 1 co-sponsor
Co-sponsor HR 842
In committee · Oregon House · Co-sponsor
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Maddy summaryThis bill adds Medicare coverage for multi-cancer early detection screening tests (blood or biological tests analyzing cell-free DNA) starting January 1, 2028. It directly affects Medicare beneficiaries aged 68 and older (starting in 2028, with the age limit increasing by 1 year annually), requiring tests to be FDA-cleared and deemed reasonable/necessary by the Secretary for early cancer detection across multiple organ sites. Payment will initially match current stool DNA test rates before 2031, then shift to a lower rate or new payment system after 2031, with limits preventing more than one test per year. The bill explicitly states it does not alter coverage for existing cancer screenings like breast, colorectal, or prostate cancer tests.

In committee Oct 3, 2025 1 co-sponsor
Co-sponsor HRES 748
In committee · Oregon House · Co-sponsor
Condemning attempts to use Federal regulatory power or litigation to suppress lawful speech, particularly speech critical of a political party or the President of the United States, and warning against the rise of authoritarianism.

Maddy summaryThis resolution condemns the use of federal regulatory agencies (like the FCC) or lawsuits to suppress lawful speech critical of political parties or the President, specifically referencing concerns about tactics mirroring authoritarian practices. It does not create new laws but formally warns that such actions undermine First Amendment protections and democratic norms. The resolution directly affects media organizations, journalists, and public discourse by calling on government agencies to avoid using their power for political retaliation. It reaffirms the House’s commitment to protecting free expression and urges officials to refrain from pressuring media to silence criticism.

In committee Sep 19, 2025 1 co-sponsor
Co-sponsor HR 5509
In committee · Oregon House · Co-sponsor
Safe Step Act

Maddy summaryThis bill requires health plans and insurers to create a clear, timely process for patients or doctors to request exceptions when step therapy protocols (which force patients to try cheaper drugs first) might harm them. It mandates approval for exceptions in six specific cases, such as when prior treatments failed, delaying care risks severe harm, or the required drug causes adverse reactions. Plans must respond within 72 hours (24 hours for emergencies) and cover the requested drug for at least one year if approved. Additionally, health plans must report annual data on exception requests, approvals, denials, and reasons to the government for transparency.

In committee Sep 19, 2025 1 co-sponsor
Showing 61 to 70 of 728 bills
Previous 1 6 7 8 73 Next